Ochratoxin A in human blood in Abidjan, Côte d'Ivoire. 2006

Béatrice Sangare-Tigori, and Serge Moukha, and James H Kouadio, and Djédjé Sébastien Dano, and Anne-Marie Betbeder, and Abdellatif Achour, and Edmond E Creppy
Department of Toxicology, University of Bordeaux 2, 146, rue Léo-Saignat, 33076 Bordeaux, France.

Ochratoxin A (OTA) produced by Aspergillus and Penicillium genera contaminates a diversity of foods including cereals; cereals-derived foods; dry fruits; beans; cocoa; coffee; beer; wine; and foodstuffs of animal origin mainly poultry, eggs, pork and milk, including human breast milk. OTA is nephrotoxic to all animal species studied so far and most likely to humans, who show the longest half-life for elimination of this toxin among all species examined. Among other toxic effects, OTA is teratogenic, immunotoxic, genotoxic, mutagenic and carcinogenic, all of which lead to life-threatening pathologies through several molecular pathways. In Côte d'Ivoire, preliminary surveys conducted by us have proven from 1998 to 2004 the reality of ochratoxin A-contamination of foodstuffs. To assess OTA in human blood, the immunoaffinity columns were used along with HPLC for separation and fluorimetric quantification of blood samples collected in Abidjan from two categories of people: apparently healthy donors (n=63) and nephropathy patients undergoing dialysis (n=39). Among healthy donors, 34.9% show OTA concentrations ranging from 0.01 - 5.81 microg/l with a mean value of 0.83 microg/l, whereas, among nephropathy patients undergoing dialysis 20.5% are OTA positive in a range of 0.167-2.42 microg/l and a mean value of 1.05. Although the sex ratio is 0.82 (46 females for 56 males) ochratoxin A contamination is equally distributed in both sexes. Nephropathy patients undergoing dialysis appear, however, less frequently contaminated than healthy donors (20.5 versus 34.9%) and show higher OTA concentrations (higher mean value, p=0.01). Ochratoxin A concentrations found in human blood reflect concentrations previously detected in cereals and peanuts according to the eating habits and diets of people in Côte d'Ivoire. But, the prevalence of ochratoxin A in blood of nephropathy people undergoing dialysis appears lower than expected from the frequency of OTA contamination in cereals and peanuts. Pearson chi(2)-test indicates that among OTA-positive individuals renal dialysis and age are important modalities for consideration.

UI MeSH Term Description Entries
D007560 Cote d'Ivoire A republic in western Africa, south of MALI and BURKINA FASO, bordered by GHANA on the east. Its administrative capital is Abidjan and Yamoussoukro has been the official capital since 1983. The country was formerly called Ivory Coast. Ivory Coast,Republic of Cote diIvoire
D007676 Kidney Failure, Chronic The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION. ESRD,End-Stage Renal Disease,Renal Disease, End-Stage,Renal Failure, Chronic,Renal Failure, End-Stage,Chronic Kidney Failure,End-Stage Kidney Disease,Chronic Renal Failure,Disease, End-Stage Kidney,Disease, End-Stage Renal,End Stage Kidney Disease,End Stage Renal Disease,End-Stage Renal Failure,Kidney Disease, End-Stage,Renal Disease, End Stage,Renal Failure, End Stage
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009793 Ochratoxins Isocoumarins found in ASPERGILLUS OCHRACEUS and other FUNGI. Ochratoxin contaminated FOOD has been responsible for cases of FOODBORNE DISEASES. Ochratoxin
D001782 Blood Donors Individuals supplying blood or blood components for transfer to histocompatible recipients. Blood Donor,Donor, Blood,Donors, Blood
D005260 Female Females
D005506 Food Contamination The presence in food of harmful, unpalatable, or otherwise objectionable foreign substances, e.g. chemicals, microorganisms or diluents, before, during, or after processing or storage. Food Adulteration,Adulteration, Food,Adulterations, Food,Contamination, Food,Contaminations, Food,Food Adulterations,Food Contaminations
D006262 Health The state of the organism when it functions optimally without evidence of disease. Individual Health,Normalcy,Normality,Health, Individual,Normalcies,Normalities
D006435 Renal Dialysis Therapy for the insufficient cleansing of the BLOOD by the kidneys based on dialysis and including hemodialysis, PERITONEAL DIALYSIS, and HEMODIAFILTRATION. Dialysis, Extracorporeal,Dialysis, Renal,Extracorporeal Dialysis,Hemodialysis,Dialyses, Extracorporeal,Dialyses, Renal,Extracorporeal Dialyses,Hemodialyses,Renal Dialyses

Related Publications

Béatrice Sangare-Tigori, and Serge Moukha, and James H Kouadio, and Djédjé Sébastien Dano, and Anne-Marie Betbeder, and Abdellatif Achour, and Edmond E Creppy
August 2016, Mycotoxin research,
Béatrice Sangare-Tigori, and Serge Moukha, and James H Kouadio, and Djédjé Sébastien Dano, and Anne-Marie Betbeder, and Abdellatif Achour, and Edmond E Creppy
January 2012, Medecine et sante tropicales,
Béatrice Sangare-Tigori, and Serge Moukha, and James H Kouadio, and Djédjé Sébastien Dano, and Anne-Marie Betbeder, and Abdellatif Achour, and Edmond E Creppy
January 1997, Bulletin de la Societe de pathologie exotique (1990),
Béatrice Sangare-Tigori, and Serge Moukha, and James H Kouadio, and Djédjé Sébastien Dano, and Anne-Marie Betbeder, and Abdellatif Achour, and Edmond E Creppy
April 1991, AIDS (London, England),
Béatrice Sangare-Tigori, and Serge Moukha, and James H Kouadio, and Djédjé Sébastien Dano, and Anne-Marie Betbeder, and Abdellatif Achour, and Edmond E Creppy
July 2022, Journal of public health in Africa,
Béatrice Sangare-Tigori, and Serge Moukha, and James H Kouadio, and Djédjé Sébastien Dano, and Anne-Marie Betbeder, and Abdellatif Achour, and Edmond E Creppy
January 2004, Bulletin de la Societe de pathologie exotique (1990),
Béatrice Sangare-Tigori, and Serge Moukha, and James H Kouadio, and Djédjé Sébastien Dano, and Anne-Marie Betbeder, and Abdellatif Achour, and Edmond E Creppy
October 2008, Bulletin de la Societe de pathologie exotique (1990),
Béatrice Sangare-Tigori, and Serge Moukha, and James H Kouadio, and Djédjé Sébastien Dano, and Anne-Marie Betbeder, and Abdellatif Achour, and Edmond E Creppy
February 2000, Bulletin de la Societe de pathologie exotique (1990),
Béatrice Sangare-Tigori, and Serge Moukha, and James H Kouadio, and Djédjé Sébastien Dano, and Anne-Marie Betbeder, and Abdellatif Achour, and Edmond E Creppy
December 2023, Human vaccines & immunotherapeutics,
Béatrice Sangare-Tigori, and Serge Moukha, and James H Kouadio, and Djédjé Sébastien Dano, and Anne-Marie Betbeder, and Abdellatif Achour, and Edmond E Creppy
February 1996, BMJ (Clinical research ed.),
Copied contents to your clipboard!